Tuesday, June 05, 2018 2:15:21 PM
It sounds to me like things aren't always done according to the book here in the OTC world. Hopefully that is NOT the case here but this company has a negative book value and some $2m in death spiral convertible debt and just signed up for $4m more in convertible debt.
It's an extremely high risk stock. Of course the hope is that the movie will be a big hit and all the debt will be 'absorbed' by increased demand.
Time will tell. So far this month the volume hasn't shown any selling to be concerned about and the price has done well. The reward MAY be worth the risk, but I DO BELIEVE there is a very high degree of risk here.
You are new here - I'm curious as to your take on their financial status and any other things related to the stock, as well as on the prospects for the movie.
My philosophy is to just be honest and balanced, and let the market decide if it agrees or not.
Recent AFOM News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 01:20:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/16/2024 10:22:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2023 07:11:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM